12.06.2019
- Keytruda, the multi-indication oncology drug manufactured by US Merck & Co, has won approval from the Food and Drug Administration (FDA) for both monotherapy and combination...
18.06.2018
- The US Food and Drug Administration (FDA) has granted two more approvals for US Merck’s Keytruda, an anti-PD-1 therapy. In the first, the drug gained its first regulatory clearance...
12.07.2017
- The US Food and Drug Administration (FDA) has placed a clinical hold on three phase 3 multiple myeloma studies testing US drugmaker Merck’s Keytruda (pembrolizumab) in combination...
14.06.2017
- US pharmaceutical giant Merck has announced it is suspending new enrollments in two phase 3 multiple myeloma studies with its blockbuster immunotherapy drug Keytruda (pembrolizumab...
06.03.2017
- Britain's health agency National Institute for Health and Care Excellence (NICE), which has responsibility for assessing the cost-effectiveness of medical treatments, has decided...
24.01.2017
- US drugmaker Merck has settled its patent dispute with rival Bristol-Myers Squibb (BMS) and Japan’s Ono Pharmaceutical over cancer immunotherapy Keytruda. Under terms of the...
07.10.2015
- The pharmaceutical industry is entering a period of sustained growth. Prescription drug sales are set to advance at almost 5% a year until 2020, while worldwide prescription drug...
10.09.2015
- UK drug cost-effectiveness agency National Institute for Health and Care Excellence, NICE, has approved the use of US drugmaker Merck’s Keytruda for treatment of certain cases of...
